wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34297594-A7BE133D-49C7-4CE8-AEFF-708A7D05F911
Q34297594-A7BE133D-49C7-4CE8-AEFF-708A7D05F911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297594-A7BE133D-49C7-4CE8-AEFF-708A7D05F911
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
P2860
Q34297594-A7BE133D-49C7-4CE8-AEFF-708A7D05F911
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297594-A7BE133D-49C7-4CE8-AEFF-708A7D05F911
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2dcd0dbfda526de6015c1f88a06a204f8ea3363d
P2860
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.